Information Journal Paper
APA:
Copy. (2019). Efficacy and Tolerability of Lopinavir/Ritonavir-and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China. FRONTIERS IN PHARMACOLOGY, 10(-), 0-0. SID. https://sid.ir/paper/702056/en
Vancouver:
Copy. Efficacy and Tolerability of Lopinavir/Ritonavir-and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China. FRONTIERS IN PHARMACOLOGY[Internet]. 2019;10(-):0-0. Available from: https://sid.ir/paper/702056/en
IEEE:
Copy, “Efficacy and Tolerability of Lopinavir/Ritonavir-and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China,” FRONTIERS IN PHARMACOLOGY, vol. 10, no. -, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/702056/en